FDA Investigator Justine Tomasso

Justine Tomasso has inspections in 6 countries as of 10 Nov 2023. Justine Tomasso has collaborated with a combinined 5162 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
75
Last Inspection Date:
10 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, Spain, India, Canada, Germany, United Kingdom of Great Britain and Northern Ireland
Co-Investigator(s):
Addam S Reynolds, Adetutu M Gidado, Alan P Kurtzberg, Alberto A Viciedo, Albinus D'sa, PhD, Albinus M D Sa, Alicia M Mozzachio, Amy L Singer, Amy M Cramer, Ana S Cabrera, Andrea A Branche, Anita Narula, PhD, Ann L Demarco, Ann Marie Montemurro, Anna Kevilag, Anna Kwilas, Anna Lazar, Annemarie B Randow, Annemarie Bodnar, Annet R Rajan, Anthony C Warchut, Anthony J Donato, Antoinette L Ravelli, Arsen Karapetyan, Arthur S Williams, Jr, Ashutosh Rao, PhD, Atul J Agrawal, Barbara J Maulfair, Barbara J Wilimczyk, Barbara Jwilimczyk Macri, Bijoy Panicker, Bo Chi, PhD, Brook Shea, Byungja E Marciante, Calvin B Koerner, Cara M Minelli, Carla J Lundi, Carol A Perry, Cary Greene, Cassandra L Abellard, Chad E Schmear, Charles J Chacko, Charles R Cote, RIC, Charlotte P Chang, Christina N Maurino, Constantin Y Philopoulos, Corey K Reno, Cynthia J Lee, MS, Cynthia Jim, CSO, Daniel J Grabicki, David A Oluwo, David H Smith, Dawn L Wydner, Demitria J Xiradakis, Denise Connelly, Denise M Visco, Investigator, Dennis Cantellops Paite, Devon Jenkins, Dhaval H Patel, Diane Kretschmer, Diane M Gubernot, Donald C Obenhuber, PhD, Donna Mwilliams Hill, Doreen P Canetti, Doreen P Gubbay, Dorothy J Denes, Douglas C Kovacs, Dr. Robert C Horan, MD, Edmund F Mrak, Jr, Edward Oshaughnessy, Emest F Bizjak, Emily A Walters, Emmanuel J Ramos, Eric J Cunningham, Eric Rothschild, Erin D Mccaffery, Farhana Khan, Ferderick Razzaghi, Frank J Marciniak, Frederick Razzaghi, George Pyramides, Gianine E Tompkins, Guerlain Ulysse, Haitao Li, Haley H Seymour, Helen B Ricalde, Helen Verdel, Herrmann, Ian F Deveau, Jacey Roy, James A Liubicich, James C Maclaughlin, James L Dunnie, Jr, James R Birkenstamm, Janet A Rajan, Janis R Armedoriz, Jason M Sluzynski, Jawaid Hamid, Jay B Shah, Jean Blackston Hill, Jean Blackstone Hill, Jean M Mulinde, MD, Jeffry A Bernhardt, Jennifer A Bazergui, Jennifer L Custodio, Jennifer Lalama, Jennifer Macmillan, Jeremy W Rotton, Jessica M Monteiro, Jill M Sooter, Jo Annc Declement, Joel D Hustedt, Jogy George, John A Gonzalez, John P Hermann, Jonathan G Matrisciano, Jonathan S Helfgott, Jonee J Mearns, Jorge L Guadalupe, Jose E Melendez, DDC, Jose M Cayuela, Joseph Duca, Joseph F Mcginnis, RPh, Jot R Klena, Joy Rkozlowski Klena, Judith A Paterson, June P Page, Junho Pak, Justin A Boyd, Karen A Spencer, Karen E D'orazio, Karen K Moksnes, Karen Takahashi, Karishma G Gopaul, Karishma Gopaul, Katherine Szestypalow, Kayla V Sprague, Kelli F Dobilas, Kelly I Anderson, Kelvin Cheung, Kenneth H Williams, Kenneth M Gordon, Kevin A Gonzalez, Kevin P Foley, Kham Phommachanh, Kim Lthomas Cruse, Kim M Wiegand, Kimberly L Schultz, Kimberly W Destromp, King, Kinh Q Mac, Ko U Min, Kris K Moore, Krishnaiah Yellela, Kristina L Conroy, Kristy A Zielny, Kristy E Zuroski, Krystal O Ogunremi, Krystyna M Kitson, Larry K Austin, Lata C Mathew, PhD, Lauren L Vajo, Li Li, Liatte Kreuger, PharmD, Libia M Lugo, Linda Thai, Lisa Harlan, Liza L Quiles, Loretta Nemchik, Lucas B Leake, Luis A Dasta, Lynda L Perry, PhD, Marcellinus D Dordunoo, Marcelo O Mangalindan, Jr, Marcia Gelber, Marcus F Yambot, Marea K Harmon, Margaret M Annes, Margaret M Sands, Margaret Sand, Maria Estrella, Maria Manzoni, PhD, Marie A Fadden, Mark W Rivero, Meisha R Sampson, Meisha Waters, Melissa T Roy, Meredith L Sheridan, Meyer J Slobotsky, Michael R Goga, Michael R Klapal, Michael Rosner, Michael Serrano, Michael Shanks, MS, Michelle A Marsh, Mielziner, Miguel A Martinez, Monica Cburgos Garcia, Monika Borkowska, Morea K Harmen, Mra Davism, Nancy F Scheraga, Nancy M Espinal, Nerizza B Guerin, Nicholas A Violand, Niketa Patel, Nimmy Mathews, Nina Yang, Paraluman S Leonin, Parul M Patel, Patricia Fhughes Troost, Patrick C Klotzbuecher, Patrick L Wisor, Patsy J Domingo, Paul E Stein, Paul L Bellamy, Paula A Trost, Peter R Lenahan, Prabhu P Raju, Pushpa S Jayasekara, Ralph Jerndal, Raymond L Cheung, Regina T Brown, Reyes Candau Chacon, PhD, Richard E Needham, Richard J Muzeni, Richard K Vogel, Rita K Kabaso, Robert C Coleman, Robin P Mathew, Rochelle L Campbell, Rochelle L Cross, Rodney D Combs, Rosario D'costa, Rose Ljean Mary, Rose M Ashley, Russell J Glapion, Ruth A Williams, Samina S Khan, Samir C Gala, Samuel K Gibbons, Jr, Sandra A Hughes, Sarah Adella Fave, Sarah Forney, Satheesh K Podaralla, Schultz, Sean G Casey, Seng Ching Hwang, Shahla Parvizi, Sharon K Thoma, PharmD, Sherri J Liu, Shirley H Isbill, Shirley S Wen, Sinai Davis, State Agency, Stephanie A Slater, MS, Stephanie T Durso, Stephen C Smith, Stephen D Brown, Stephen J Mottola, Steven M Weinman, Susan F Laska, MS, Susan M Jackson, Susan M Turcovski, Susanna E Ford, Analyst, Tamil Arasu, PhD, Tara G Bizjak, Tara M Aikens, Tara M Humfeld, Tara R Gooen, Teigan M Mule, Temar Q Williams, Thomas J Arista, Tonia F Bernard, Torrance J Slayton, Toyin B Oladimeji, Tressa T Lewis, Tyanna N Hadley, Unnee Ranjan, Victoria A Wagoner, Victoria Spivak, Virgilio F Pacio, CSO, Wayne J Meyer, William J Muszynski, William R Chang, William W Dotts, Yangmin Ning, Yasamin Ameri, Yehualashet A Gessesse, Yong Wu, PhD, Yumi J Hiramine, Yvesna C Blaise, Yvins Dezan, Yvonne C Mcknight, Zakaria I Ganiyu

Justine Tomasso's Documents

Publish Date Document Type Title
March, 2013 FDA 483 Response CorePharma, LLC - Form 483R, 2013-04-11
March, 2011 FDA 483 BASF Corporation - Form 483, 2011-03-22
March, 2013 FDA 483 CorePharma, LLC - Form 483, 2013-03-26
March, 2012 FDA 483 Guardian Drug Company - Form 483, 2012-03-02
January, 2010 FDA 483 CorePharma, LLC - Form 483, 2010-01-20
August, 2012 FDA 483 GE Healthcare, Inc. - Form 483, 2012-08-20
April, 2010 FDA 483 Sun Pharmaceutical Industries, Inc. - Form 483, 2010-04-28
January, 2012 EIR Infinity Labs NJ, LLC - EIR, 2012-01-04
June, 2010 EIR Aspire Pharmaceuticals Inc. - EIR, 2010-06-21
August, 2014 FDA 483 DNA Pharmacy Services Inc dba Palm Beach Compounding - Form 483, 2014-08-13
October, 2012 FDA 483 Roche Diagnostics GmbH - Form 483, 2012-10-16
July, 2012 EIR CELGENE CORPORATION - EIR, 2012-07-30
June, 2010 FDA 483 Response Aspire Pharmaceuticals Inc. - Form 483R, 2010-07-01
May, 2013 FDA 483 Sun Pharmaceutical Industries, Inc. - Form 483, 2013-05-16
July, 2017 FDA 483 LEESAR, INC - Form 483, 2017-07-12
August, 2010 EIR Reliance Private Label Supplements - EIR, 2010-08-03
June, 2013 EIR Hikma Pharmaceuticals USA Inc. - EIR, 2013-06-14
January, 2011 FDA 483 Response H & P Industries, Inc. - Form 483R, 2011-01-28
November, 2010 FDA 483 H & P Industries, Inc. - Form 483, 2010-11-10
September, 2011 FDA 483 Pax-All Manufacturing Inc - Form 483, 2011-09-23
March, 2013 EIR CorePharma, LLC - EIR, 2013-03-26
April, 2013 EIR Celgene Corporation - EIR, 2013-04-24
March, 2011 EIR Infinity Labs NJ, LLC - EIR, 2011-03-31
August, 2009 EIR Curia New Jersey, LLC - EIR, 2009-08-05
April, 2009 FDA 483 Johnson & Johnson Pharmaceutical Research & Development, LLC - Form 483, 2009-04-14
August, 2014 FDA 483 LEESAR, INC - Form 483, 2014-08-08
January, 2011 FDA 483 H & P Industries, Inc. - Form 483, 2011-01-07
June, 2012 FDA 483 CorePharma, LLC - Form 483, 2012-06-11
October, 2012 FDA 483 AbbVie Deutschland GmbH & Co KG - Form 483, 2012-10-25
December, 2012 EIR Ohm Laboratories Inc. - EIR, 2012-12-18
March, 2012 EIR Guardian Drug Company - EIR, 2012-03-02
December, 2012 FDA 483 Ohm Laboratories Inc. - Form 483, 2012-12-18
May, 2013 EIR Sun Pharmaceutical Industries, Inc. - EIR, 2013-05-16
April, 2012 EIR Novo Nordisk Inc. - EIR, 2012-04-03
July, 2012 FDA 483 CELGENE CORPORATION - Form 483, 2012-07-30
November, 2011 EIR International Vitamin Corporation - EIR, 2011-11-21
September, 2012 FDA 483 LTS Lohmann Therapy Systems Corp. - Form 483, 2012-09-11
June, 2011 FDA 483 Sun Pharmaceutical Industries, Inc. - Form 483, 2011-06-28
April, 2013 FDA 483 Celgene Corporation - Form 483, 2013-04-24
November, 2011 FDA 483 International Vitamin Corporation - Form 483, 2011-11-21
April, 2009 EIR Johnson & Johnson Pharmaceutical Research & Development, LLC - EIR, 2009-04-14
January, 2011 EIR H & P Industries, Inc. - EIR, 2011-01-07
June, 2010 FDA 483 Aspire Pharmaceuticals Inc. - Form 483, 2010-06-21

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more